ERD

Sort by

European Partnerships

Show in overview

EU-Programme-Call

Show in overview

8 items found

Toggle all information

CCI4EU | COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

01-05-2023

30-04-2026

Show more information

Organisation UNICANCER

MyPeBS | International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70

01-01-2018

30-06-2026

Show more information

Organisation UNICANCER

EUonQoL | Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

01-01-2023

31-12-2026

Show more information

Organisation UNICANCER

DEFINITIVE | Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer

01-12-2023

30-11-2028

Show more information

Organisation UNICANCER

ONCOBIOME | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.

01-01-2019

30-06-2025

Show more information

Organisation UNICANCER

PragmaTIL | Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

01-04-2023

31-03-2028

Show more information

Organisation UNICANCER

PRE-ACT | PRE-ACT: Prediction of Radiotherapy side Effects using explainable AI for patient Communication and Treatment modification

01-10-2022

30-09-2027

Show more information

Organisation UNICANCER

DE-ESCALATE | INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL

01-06-2023

31-05-2028

Show more information

Organisation UNICANCER

Projects overview

Selected filters:

CCI4EU | COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

MyPeBS | International Randomized Study Comparing personalized, Risk-Stratified to Standard Breast Cancer Screening In Women Aged 40-70

EUonQoL | Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

DEFINITIVE | Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer

ONCOBIOME | Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.

PragmaTIL | Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

PRE-ACT | PRE-ACT: Prediction of Radiotherapy side Effects using explainable AI for patient Communication and Treatment modification

DE-ESCALATE | INTERMITTENT ANDROGEN DEPRIVATION THERAPY IN THE ERA OF ANDROGEN RECEPTOR PATHWAY INHIBITORS; A PHASE 3 PRAGMATIC RANDOMISED TRIAL